HPV Vaccination: Dos, Don'ts, and Efficacy
The HPV vaccine is highly effective and should be routinely administered to all children aged 11-12 years (can start as early as age 9), with catch-up vaccination recommended through age 26 years for those not previously vaccinated. 1
Vaccination Schedule
Dos:
- Administer HPV vaccine according to age-appropriate schedules:
- Prioritize vaccination before sexual debut for maximum effectiveness 2, 1
- Provide catch-up vaccination for all unvaccinated individuals through age 26 2
- Consider shared decision-making for adults aged 27-45 who may benefit from vaccination 2
- Administer HPV vaccine at the same visit as other age-appropriate vaccines 2
Don'ts:
- Don't delay vaccination until sexual activity begins 2, 1
- Don't administer during pregnancy (postpone until after pregnancy) 2
- Don't skip cervical cancer screening after vaccination 2, 1
- Don't require HPV testing or Pap tests before vaccination 2
- Don't assume vaccination is ineffective for sexually active individuals (they may still benefit from protection against HPV types they haven't been exposed to) 2
Efficacy
The HPV vaccine demonstrates excellent efficacy when administered before exposure to HPV:
- Prevents 70% of cervical cancers (HPV types 16/18) 2
- Prevents 90% of genital warts (HPV types 6/11) 2
- Prevents anal HPV infection and anal intraepithelial neoplasia with 77.5% efficacy 1, 3
- Highly immunogenic with highest antibody responses in ages 9-15 years 2
- Provides protection for at least 5 years without evidence of waning protection 2
- Reduces HPV prevalence in vaccinated populations, showing real-world effectiveness 3, 4
Special Populations
Immunocompromised Individuals:
Individuals with Abnormal Pap Tests:
Breastfeeding Women:
- Can safely receive HPV vaccination 2
Common Pitfalls to Avoid
Delaying vaccination until sexual debut: Maximum benefit occurs when administered before any HPV exposure 2, 1
Assuming no benefit for sexually active individuals: Most sexually active people have not been exposed to all vaccine HPV types and can still benefit from vaccination 2
Discontinuing cervical cancer screening after vaccination: The vaccine does not protect against all HPV types that cause cervical cancer, so screening must continue 2, 1
Administering incorrect dosing schedule: Follow the 2-dose schedule for ages 9-14 and 3-dose schedule for ages 15+ 2, 1
Missing minimum intervals between doses: Minimum interval is 4 weeks between doses 1 and 2, and 12 weeks between doses 2 and 3 2
The current 9-valent HPV vaccine (Gardasil 9) protects against nine HPV types (6,11,16,18,31,33,45,52, and 58), providing broader coverage than earlier vaccine formulations 5, 3.